SMMT icon

Summit Therapeutics
SMMT

Overview Fund Activity

8 hedge funds and large institutions have $33.2M invested in Summit Therapeutics in 2015 Q1 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
8
Holders Change
+8
Holders Change %
–
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
LPU
1
Lansdowne Partners (UK)
United Kingdom
$11.5M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$10.4M
3
Axa
3
Axa
France
$3.63M
4
First Eagle Investment Management
4
First Eagle Investment Management
New York
$2.17M
5
SFM
5
Sphera Funds Management
Israel
$2.17M

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
LPU
1
Lansdowne Partners (UK)
United Kingdom
$11.5M 930,000 +930,000 New
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$10.4M 843,300 +843,300 New
Axa
3
Axa
France
$3.63M 292,907 +292,907 New
First Eagle Investment Management
4
First Eagle Investment Management
New York
$2.17M 175,000 +175,000 New
SFM
5
Sphera Funds Management
Israel
$2.17M 175,000 +175,000 New
Janus Henderson Group
6
Janus Henderson Group
United Kingdom
$1.72M 139,166 +139,166 New
GPCM
7
Granite Point Capital Management
Massachusetts
$1.55M 125,000 +125,000 New
TRCT
8
Tower Research Capital (TRC)
New York
$0 5 +5 New